LakeShore Biopharma Co Performance
| LSBDelisted Stock | 0.63 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.064, which conveys not very significant fluctuations relative to the market. As returns on the market increase, LakeShore Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding LakeShore Biopharma is expected to be smaller as well. At this point, LakeShore Biopharma has a negative expected return of -0.18%. Please make sure to verify LakeShore Biopharma's variance, value at risk, as well as the relationship between the Value At Risk and rate of daily change , to decide if LakeShore Biopharma performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days LakeShore Biopharma Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Begin Period Cash Flow | 246.6 M | |
| Total Cashflows From Investing Activities | -17 M |
LakeShore |
LakeShore Biopharma Relative Risk vs. Return Landscape
If you would invest 70.00 in LakeShore Biopharma Co on October 23, 2025 and sell it today you would lose (7.00) from holding LakeShore Biopharma Co or give up 10.0% of portfolio value over 90 days. LakeShore Biopharma Co is generating negative expected returns assuming volatility of 7.0851% on return distribution over 90 days investment horizon. In other words, 63% of stocks are less volatile than LakeShore, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
LakeShore Biopharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LakeShore Biopharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LakeShore Biopharma Co, and traders can use it to determine the average amount a LakeShore Biopharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0251
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LSB |
Based on monthly moving average LakeShore Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LakeShore Biopharma by adding LakeShore Biopharma to a well-diversified portfolio.
LakeShore Biopharma Fundamentals Growth
LakeShore Stock prices reflect investors' perceptions of the future prospects and financial health of LakeShore Biopharma, and LakeShore Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LakeShore Stock performance.
| Return On Equity | -0.18 | |||
| Return On Asset | -0.0215 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.69) % | |||
| Current Valuation | 88.96 M | |||
| Shares Outstanding | 41.21 M | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 614.96 M | |||
| EBITDA | (48.54 M) | |||
| Total Debt | 414.4 M | |||
| Book Value Per Share | 24.07 X | |||
| Cash Flow From Operations | (120.98 M) | |||
| Earnings Per Share | (0.73) X | |||
| Total Asset | 1.37 B | |||
| Retained Earnings | (2.41 B) | |||
About LakeShore Biopharma Performance
By analyzing LakeShore Biopharma's fundamental ratios, stakeholders can gain valuable insights into LakeShore Biopharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LakeShore Biopharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LakeShore Biopharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about LakeShore Biopharma performance evaluation
Checking the ongoing alerts about LakeShore Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LakeShore Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LakeShore Biopharma is not yet fully synchronised with the market data | |
| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has some characteristics of a very speculative penny stock | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 614.96 M. Reported Net Loss for the year was (99.98 M) with profit before taxes, overhead, and interest of 507.19 M. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| About 88.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Insider Trading |
- Analyzing LakeShore Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LakeShore Biopharma's stock is overvalued or undervalued compared to its peers.
- Examining LakeShore Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LakeShore Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LakeShore Biopharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LakeShore Biopharma's stock. These opinions can provide insight into LakeShore Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in LakeShore Stock
If you are still planning to invest in LakeShore Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LakeShore Biopharma's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |